October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Emicizumab Approvals in Europe: European Haemophilia Consortium Shares Key Updates
Oct 1, 2025, 16:30

Emicizumab Approvals in Europe: European Haemophilia Consortium Shares Key Updates

 

European Haemophilia Consortium (EHC) posted on LinkedIn:

”Indications of non-factor treatments for haemophilia A are evolving.

In Europe, Emicizumab is approved for routine prophylaxis for moderate haemophilia A with severe bleeding, for severe haemophilia A and for haemophilia A with factor VIII inhibitors.

It is always a good idea to consult local regulatory authorities for the precise current approved use in your area.

Learn more in the EHCucate topic Emicizumab Basics, available on the EHC Academy.”

Haemophilia

 

 

 

 

 

Stay updated with Hemostasis Today.